Increased Risk of Necrotizing Enterocolitis in Premature Infants with Patent Ductus Arteriosus Treated with Indomethacin
Data up to Jan 2025
Total Citations Per Year
Abstract
References (25)
Effects of indomethacin in premature infants with patent ductus arteriosus: Results of a national collaborative study
1983 • 558 citations
Prevention of Necrotizing Enterocolitis in Low-Birth-Weight Infants by IgA–IgG Feeding
1988 • 318 citations
Prenatal and postnatal corticosteroid therapy to prevent neonatal necrotizing enterocolitis: a controlled trial
1990 • 191 citations
Early Ibuprofen Administration to Prevent Patent Ductus Arteriosus in Premature Newborn Infants
1996 • 182 citations
Prophylactic Indomethacin Therapy for Patent Ductus Arteriosus in Very-Low-Birth-Weight Infants
1982 • 182 citations
A randomized, placebo-controlled trial of recombinant human granulocyte colony-stimulating factor administration in newborn infants with presumed sepsis: significant induction of peripheral and bone marrow neutrophilia
1994 • 177 citations
A bone marrow stromal-derived growth factor, interleukin-11, stimulates recovery of small intestinal mucosal cells after cytoablative therapy
1994 • 161 citations
Gastrointestinal perforation following indomethacin therapy in very low birth weight infants
1981 • 154 citations
Spontaneous, isolated intestinal perforations in neonates with birth weight < 1,000 g not associated with necrotizing enterocolitis
1991 • 123 citations
Changing Trends in Necrotizing Enterocolitis
1991 • 119 citations
Indications for operation in necrotizing enterocolitis revisited
1994 • 116 citations
Localized intestinal perforations after enteral administration of indomethacin in premature infants
1985 • 114 citations
Optimal management of patent ductus arteriosus in the neonate weighing less than 800 g
1993 • 103 citations
Oligohydramnios, renal insufficiency, and ileal perforation in preterm infants after intrauterine exposure to indomethacin
1988 • 96 citations
Age-dependent changes in the response of the lamb ductus arteriosus to oxygen and ibuprofen
1979 • 89 citations
Clinical Comparison of Localized Intestinal Perforation and Necrotizing Enterocolitis in Neonates
1994 • 88 citations
Comparative effects of Indomethacin, Prostaglandin E1, and Ibuprofen on bowel ischemia
1983 • 67 citations
Hemodynamically significant PDA: An echocardiographic and clinical assessment of incidence, natural history, and outcome in very low birth weight infants maintained in negative fluid balance
1985 • 67 citations
Granulocyte Macrophage Colony-Stimulating Factor Improves Survival in Two Models of Gut-Derived Sepsis by Improving Gut Barrier Function and Modulating Bacterial Clearance
1994 • 63 citations
Intestinal perforation associated with indomethacin treatment in premature infants
1985 • 42 citations
Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants
1996 • 37 citations
Management of Patent Ductus Arteriosus in the Premature Infant: Indomethacin versus Ligation
1983 • 34 citations
Intravenous Indomethacin therapy in preterm neonates with patent ductus arteriosus
1991 • 32 citations
The protective role of enteral IgA supplementation in neonatal gut origin sepsis
1995 • 32 citations
Gastric perforation associated with indomethacin therapy in a pre-term infant.
1980 • 5 citations
Cited By (0)
No citing papers found in database